Skip to main content
. 2019 Jul 5;23(9):6295–6307. doi: 10.1111/jcmm.14515

Figure 6.

Figure 6

miR‐516a‐3p reduces indicated protein expression of the Wnt pathway in human breast cancer cells. A, Western blot analysis of the β‐catenin, c‐Myc and cyclinD1 protein expression in MCF‐7 and MDAMB‐231 breast cancer cell lines transfected with miR‐516a‐3p NC or miR‐516a‐3p mimic. B, Western blot showing the β‐catenin, c‐Myc, and cyclinD1 protein expression in MCF‐7 and MDA‐MB‐231 breast cancer cell lines transfected with miR‐516a‐3p NC or miR‐516a‐3p inhibitor. Data are shown as mean ± SD (*, P < 0.05; **, P < 0.01; ***, P < 0.001)